iCMLf Knowledge Centre

eLearning for Clinicians, Molecular Biologists, & Pathologists

iCMLf Knowledge Center


Diary Dates

Save the date for important iCMLf meetings and programs

Become a member

Become an iCMLf member - help shape our future

Please donate

Support our activities
by donating
Donate here


We thank all our supporters and partners


If you are not a member, please click on "Register". If you have forgotten your password, please click on "Forgot login?" below.

EU e-Privacy Directive

Welcome to the iCMLf Virtual Education Program

This Virtual Education Program, provided by the iCMLf offers a series of webcast presentations from leading hematologists.

These presentations provide updated information on treatment advances and best practice management of CML, including disease monitoring and new therapies. The sessions specifically address issues of CML care in countries with limited access to monitoring and supplemental treatments.


Modules des langues français

Módulos en español


 -- Virtual Education Program: 2017 Edition


Presentations from a CML Opinion Leader Meeting

We are pleased to make available a new series of presentations from the COLT Meeting 2017, a CML Opinion Leader Training that took place in Adelaide (Australia). Modules currently featured include; frontline CML, TKI resistance/failure, future directions for CML, CML related topics and the CML frontier - all presented by leaders in the field. 

Collage COLT 2017 Session 5

Prof. Timothy Hughes     Dr Agnes Yong



Session 5: The CML frontier
  • Making TFR mainstream 
    (Prof. Timothy Hughes)
  • The immunology of CML and immunomodulation
    (Dr Agnes Yong)


Read more ...




       Dr Naranie Shanmuganathan



 Session 4: CML related topics

  • Managing TKI toxicities 
    (Dr Naranie Shanmuganathan)


Read more ...


Collage VEP Ross White

  Dr David Ross     Dr Deborah White




 Session 3: Future directions for CML

  • TFR trial update 
    (Dr David Ross)
  • Biomarkers and response prediction 
    in CML
    (Dr Deborah White)


Read more ...

Presentations from the 19th John Goldman Conference on CML

We are pleased to make available a couple presentations recorded during the scientific sessions at the 19th Annual John Goldman Conference on CML in Estoril. Presentations currently featured include response to front-line imatinib treatment in children and adolescents and factors affecting adherence in CML and ways to improvement. More presentations will be made available over the next couple of weeks.

VEP Suttorp

Response to front-line imatinib treatment in children and adolescents with CML -
data from a large pediatric cohort
Meinolf Suttorp, University Hospital Dresden, Germany 

  • Study design
  • Hematological findings at diagnosis
  • Imatinib dose, monitoring, and methods
  • Cytogenetic response in patients with CML-CP
  • Molecular response in patients with CML-CP
  • Impairment of growth in pediatric patients on imatinib
  • Probability of PFS in patients diagnosed in CML-CP
  • Summary

Read more ...

Marc Delord






Burden of CML in China and India:
The rising incidence and prevalance of the disease
Marc Delord, Université Paris Diderot, France 

  • Basic CML epidemiology
  • India and China demographics
  • Incidence of CML in India and China
  • Prevalence of CML in India and China
  • Conclusions and perspectives

Read more ...